Cargando…
The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China
BACKGROUND: The novel coronavirus disease 2019 (COVID-19) broke out globally. Early prediction of the clinical progression was essential but still unclear. We aimed to evaluate the timeline of COVID-19 development and analyze risk factors of disease progression. METHODS: In this retrospective study,...
Autores principales: | Wang, Fang, Qu, Mengyuan, Zhou, Xuan, Zhao, Kai, Lai, Changxiang, Tang, Qiyuan, Xian, Wenjie, Chen, Ruikun, Li, Xuan, Li, Zhiyu, He, Qing, Liu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332535/ https://www.ncbi.nlm.nih.gov/pubmed/32620125 http://dx.doi.org/10.1186/s12967-020-02423-8 |
Ejemplares similares
-
Shorter incubation period is associated with severe disease progression in patients with COVID-19
por: Lai, Changxiang, et al.
Publicado: (2020) -
Comparison of Clinical Characteristics and Outcomes of Pediatric and Adult Patients with Coronavirus Disease 2019 in Shenzhen, China*
por: WANG, Fang, et al.
Publicado: (2020) -
Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility
por: Wang, Fang, et al.
Publicado: (2020) -
Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen, China
por: Tang, Xiujuan, et al.
Publicado: (2020) -
Cardiac manifestations of COVID-19 in Shenzhen, China
por: Zeng, Jia-Hui, et al.
Publicado: (2020)